Related Experiment Video
Updated: Nov 21, 2025

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
SubtypeDrug: a software package for prioritization of candidate cancer subtype-specific drugs
Xudong Han1, Qingfei Kong2, Chonghui Liu2
1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
Summary:
Cancer can be classified into various subtypes by its molecular, histological or clinical characteristics. Discovering cancer-subtype-specific drugs is a crucial step in personalized medicine. SubtypeDrug is a system biology R-based software package that enables the prioritization of subtype-specific drugs based on cancer expression data from samples of many subtypes. This provides a novel approach to identify the subtype-specific drug by considering biological functions regulated by drugs at the subpathway level. The operation modes include extraction of subpathways from biological pathways, identification of dysregulated subpathways induced by each drug, inference of sample-specific subpathway activity profiles, evaluation of drug-disease reverse association at the subpathways level, identification of cancer-subtype-specific drugs through subtype sample set enrichment analysis, and visualization of the results. Its capabilities enable SubtypeDrug to find subtype-specific drugs, which will fill the gaps in the recent tools which only identify the drugs for a particular cancer type. SubtypeDrug may help to facilitate the development of tailored treatment for patients with cancer.
Availability And Implementation:
The package is implemented in R and available under GPL-2 license from the CRAN website (https://CRAN.R-project.org/package=SubtypeDrug).
Supplementary Information:
Supplementary data are available at Bioinformatics online.
Insights
SubtypeDrug prioritizes cancer-subtype-specific drugs using R, analyzing molecular data to identify targeted therapies. This system biology approach aids personalized cancer medicine by revealing drugs effective for specific cancer subtypes.
Area of Science:
- Bioinformatics
- Computational Biology
- Genomics
Background:
- Cancer heterogeneity necessitates subtype-specific treatments for effective personalized medicine.
- Existing tools often lack the granularity to identify drugs tailored to specific cancer subtypes.
Purpose of the Study:
- To develop a novel R-based software package, SubtypeDrug, for prioritizing cancer-subtype-specific drugs.
- To enable identification of drugs targeting specific molecular or histological cancer subtypes.
Main Methods:
- SubtypeDrug utilizes a systems biology approach, analyzing cancer expression data.
- It identifies dysregulated subpathways and infers sample-specific activity profiles.
- Drug-disease reverse association is evaluated at the subpathway level.
Main Results:
- SubtypeDrug successfully identifies cancer-subtype-specific drugs by analyzing expression data.
- The software enables prioritization of drugs based on subpathway-level biological functions.
- It facilitates a novel approach to drug discovery for tailored cancer treatments.
Conclusions:
- SubtypeDrug offers a novel computational approach to identify subtype-specific drugs, addressing limitations of current tools.
- This R package supports the development of personalized medicine by facilitating tailored cancer treatments.
- SubtypeDrug aids in discovering drugs effective for distinct cancer subtypes, advancing precision oncology.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drug Discovery: Overview